We commend the investigators on completion of this randomized multicenter study—the ISG-STS 1001 study—in high-grade myxoid liposarcoma (HG-MLPS), 1 showing that neoadjuvant trabectedin chemotherapy ...
We identified 276 patients with primary retroperitoneal WDLS and 353 patients with primary retroperitoneal DDLS who underwent resection between July 1982 and July 2021 at our institution. WDLS ...
New research from Memorial Sloan Kettering Cancer Center (MSK) reports encouraging results for a new liposarcoma treatment; describes more potent CAR T cells that can be given at lower doses; relates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback